Loose end  by Brenner, Sydney
/I e I0 , have received several invitations to(L0o 05 Ilgenome meetings and been asked
e C4S to talk on subjects such as "After the
rlUImail "enoLnC - wna IXL, or
"From sequence to function -
prospects for the future". As was
predicted at the beginning of the
Human Genome Project, getting the
sequence will be the easy part as only
technical issues are involved. The hard
part will be finding out what it
means, because this poses intellectual
problems of how to understand the
participation of the genes in the
functions of living cells. The Human
Genome Project was once compared
tt-. n11ttin mn an tP mann ,nnn thp
similarity is deeper than just the cost:
sending men to the moon is easy, it's
getting them back that is costly and difficult. The real
work in biology is now only beginning and we are now
entering what Jurgen Drews has called the post-
genomics phase.
How does one go from sequence to function? In classical
experimental genetics, genes were identified by finding
mutants. There was no other way to define a wild-type
gene; we needed the mutant allele with a phenotypic
alteration. Mendel could not assert that there was a
factor (gene) for the character of tallness until he found
dwarf mutants displaying a lack of tallness. Although we
had great difficulties in resolving the functions of any
particular gene at the molecular level, the mutants were
selected for altered functions and thus experimental
genetics was rooted in physiology. By itself, genetic
analysis - the isolation and complementation of mutants
- gave us only a classification and told us something of
the grammar of the system. With very few exceptions, it
was not possible to come to any deep conclusions about
function and structure. Only when genetic analysis was
coupled with powerful methods of in vitro biochemical
analysis did the full power of this approach emerge.
In fungi and bacteria, for example, nutritional mutants
(auxotrophs) opened the door to the enzymology of
small molecule biosynthesis. A mutant extract provides
an assay system for the purified missing component, and
this was also the method used in studying DNA
replication, where many new components were
discovered by using conditional lethal mutants of DNA
synthesis. Bacteriophage self-assembly is another example
where the combination of simple electron microscopy
and in vitro complementation led to the understanding of
how a structurally complex particle is assembled from
many different components.
It was the success of this genetic approach that led several
molecular biologists in the 1960s to try to apply it to
more complex biological processes. The burgeoning
industries of yeast, Caenorhabditis, Drosophila and
Arabidopsis genetics and biological research stem from
those initiatives. The injunction was: find mutants and
study them as deeply as you can.
Of course, when cloning and sequencing came along in
the mid 1970s, all of these fields experienced a
revolutionary change, because these were exactly the
tools we needed to get to grips with the molecular basis
of the mutant dysfunction, and the new and the old
genetics flowed seamlessly into each other. When we
come to humans or, for that matter, other vertebrates,
we have relatively little in the way of an experimental
genetic resource. There are some useful mouse mutants
and human genetic diseases, and these are under
intensive study. The most profound sources of mutant
genes are those found in naturally occurring cancer cells,
and the study of these combined with biochemical
analyses have led to extensive knowledge of growth
control and DNA repair in mammalian cells. But still the
genetic approach is severely hampered.
Reverse genetics has been proposed as a solution. In
normal genetics we have the phenotype and we then
look for the gene; in reverse genetics, we have the gene
but not the phenotype, so we find what that is by
mutating the gene. But this really does not help, except
to connect genes and phenotype, although, of course, it
can and should be used to test hypotheses about function.
The only way out is through biochemistry of one kind
or another. In 1990, I made the remark that
biochemistry and communism seemed to have
disappeared in that year. Most people thought I said this
with glee, but in fact it was with regret, at least for
biochemistry. There is another subject that disappeared a
few decades ago which we also need to reinvent, and
that is physiology. Classical physiology was concerned
with the functions of organisms and we are now
grappling with the physiology of the cell. In the 1930s
R. Goldschmidt wrote a book on Physiological
Genetics: what we need today is the modern text. I have
also frequently heard it said that what we now need to
do is integrative biology; that we are very good at
working out how simple systems with few components
work but very bad at putting the parts of multi-
component systems together. For the latter, I believe we
are going to need two things. After all, the machinery of
the cell performs the integration of all its component
functions, so that cells can display integrated behaviour.
So the first requirement will be for a theoretical
framework in which to embed all of the detailed
knowledge we have accumulated, to allow us to
compute outcomes of the complex interactions and to
start to understand the dynamics of the system. The
second will be the ability to make parallel measurements
of the behaviour of many components during the
execution by the cell of an integrated action in order to
test whether the theory is right. Is there some other
approach? If I knew it, I would be doing it, and not
writing about the problem.
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